Leadership Overview
HNL Lab Medicine has 7 executives leading key functions including strategy, marketing, finance, operations, administration, and clinical oversight.
Committed to diagnostic excellence, HNL Lab Medicine delivers comprehensive clinical and anatomic pathology services to hospitals and healthcare providers across Pennsylvania and New Jersey, ensuring precise medical insights for diverse patient populations.
Committed to diagnostic excellence, HNL Lab Medicine delivers comprehensive clinical and anatomic pathology services to hospitals and healthcare providers across Pennsylvania and New Jersey, ensuring precise medical insights for diverse patient populations.
Leadership Roles at HNL Lab Medicine
Martin Till - President & Chief Executive Officer
Martin Till, the President & Chief Executive Officer at HNL Lab Medicine, directs the overarching strategic vision for the organization. Focusing on clinical diagnostic expansion, the President & Chief Executive Officer architects long-term growth initiatives across Pennsylvania and New Jersey. This leadership role involves constant collaboration with the Board to ensure the laboratory maintains high standards of medical accuracy. By prioritizing technological integration within the diagnostic workflow, Martin Till drives operational efficiency and service quality for hospital partners. The President & Chief Executive Officer oversees the alignment of laboratory resources with the evolving needs of healthcare providers. Through rigorous market analysis, the President & Chief Executive Officer secures the competitive position of the company within the regional health services sector. Ultimately, the President & Chief Executive Officer fosters a culture of innovation that supports the delivery of critical pathology results to diverse patient populations.
David Beckwith - President & Chief Executive Officer
David Beckwith, the President & Chief Executive Officer at HNL Lab Medicine, manages the institutional partnerships and external stakeholder relations. Concentrating on the industrial and employer-based testing segments, the President & Chief Executive Officer expands the reach of diagnostic services throughout the regional market. This leadership role requires constant coordination with healthcare systems to optimize the delivery of laboratory results. By streamlining the interface between physician offices and the laboratory, David Beckwith enhances the speed and reliability of diagnostic reporting. The President & Chief Executive Officer monitors the performance of regional testing facilities to ensure consistent service delivery. Through strategic outreach, the President & Chief Executive Officer strengthens the presence of the organization among long-term care facilities. Ultimately, the President & Chief Executive Officer maintains the operational integrity of the laboratory network while supporting the broader mission of providing accessible, high-quality medical testing services.
David Confalone - Chief Financial Officer
David Confalone, the Chief Financial Officer at HNL Lab Medicine, manages the fiscal health and capital allocation for the entire laboratory network. Overseeing the financial planning and analysis departments, the Chief Financial Officer ensures the sustainability of diagnostic operations across the region. This leadership role involves rigorous oversight of revenue cycles and cost management strategies to support the delivery of high-quality pathology services. By optimizing the financial structure, David Confalone enables the company to invest in advanced testing technologies and infrastructure. The Chief Financial Officer works closely with the executive team to evaluate the economic impact of new service lines and regional expansions. Through precise budgeting and risk assessment, the Chief Financial Officer maintains the financial stability required for long-term growth. Ultimately, the Chief Financial Officer provides the fiscal foundation necessary for the organization to continue serving hospitals, employers, and patients with reliable diagnostic results.
Warren Erdmann - Chief Operating Officer
Warren Erdmann, the Chief Operating Officer at HNL Lab Medicine, directs the daily laboratory workflows and logistics across all testing locations. Overseeing the technical staff and specimen processing systems, the Chief Operating Officer ensures the timely delivery of clinical and anatomic pathology results. This leadership role involves managing the complex supply chain and equipment maintenance required for high-volume diagnostic services. By implementing lean methodologies, Warren Erdmann improves the efficiency of laboratory operations throughout Pennsylvania and New Jersey. The Chief Operating Officer coordinates with the medical leadership to maintain strict quality control standards in every facility. Through the optimization of internal processes, the Chief Operating Officer supports the rapid turnaround times expected by healthcare providers. Ultimately, the Chief Operating Officer maintains the operational excellence of the laboratory, ensuring that every test performed meets the highest standards of accuracy and reliability for the patient population.
Jessica Bargilione - Chief Marketing Officer
Jessica Bargilione, the Chief Marketing Officer at HNL Lab Medicine, directs all brand positioning and communication strategies for the laboratory. Overseeing the promotion of clinical and anatomic pathology services, the Chief Marketing Officer ensures that healthcare providers understand the full scope of diagnostic capabilities available. This leadership role involves developing targeted campaigns that highlight the value of laboratory services to hospitals and physician offices. By analyzing market trends across Pennsylvania and New Jersey, Jessica Bargilione identifies new opportunities for service expansion. The Chief Marketing Officer collaborates with the executive team to align promotional efforts with the overall growth objectives of the company. Through effective engagement strategies, the Chief Marketing Officer builds strong relationships with industrial clients and medical partners. Ultimately, the Chief Marketing Officer elevates the reputation of the organization as a premier provider of diagnostic solutions, ensuring consistent visibility and market relevance.
Angela Connell - Chief Administrative Officer
Angela Connell, the Chief Administrative Officer at HNL Lab Medicine, directs the internal infrastructure and organizational support systems. Overseeing human resources, compliance, and facility management, the Chief Administrative Officer ensures that the laboratory operates within all regulatory frameworks. This leadership role involves fostering a productive work environment that supports the clinical and technical teams. By streamlining administrative processes, Angela Connell enhances the overall efficiency of the organization. The Chief Administrative Officer collaborates with other executives to implement policies that align with the mission of providing superior diagnostic services. Through the management of corporate resources, the Chief Administrative Officer supports the expansion of laboratory operations across the region. Ultimately, the Chief Administrative Officer maintains the organizational stability and compliance posture necessary for the company to deliver consistent, high-quality medical testing services to hospitals, physician offices, and industrial clients throughout the service area.
Jordan Olson - Chief Medical Officer
Jordan Olson, the Chief Medical Officer at HNL Lab Medicine, directs the clinical standards and pathology practices for the entire organization. Overseeing the medical staff and diagnostic protocols, the Chief Medical Officer ensures the accuracy and clinical relevance of all laboratory results. This leadership role involves maintaining the highest levels of scientific integrity in clinical and anatomic pathology services. By guiding the implementation of new diagnostic tests, Jordan Olson keeps the laboratory at the forefront of medical innovation. The Chief Medical Officer collaborates with hospital partners to address complex diagnostic needs and improve patient outcomes. Through continuous monitoring of quality assurance metrics, the Chief Medical Officer upholds the reputation of the company as a trusted medical resource. Ultimately, the Chief Medical Officer provides the clinical leadership necessary to support the diverse healthcare needs of patients and providers across Pennsylvania and New Jersey.
Explore Leadership Teams in Healthcare Services
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management. The company offers physicians the broadest test menu, is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staf
Company Leadership EY
CR
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
Company Leadership
CC

BC
Aegis is a forensic toxicology and healthcare sciences laboratory. The company was founded in 1986 and is based in Nashville, Tennessee. Aegis was formerly known as Aegis Analytical Laboratories, Inc.
Company Leadership DS

BC
TR
RadNet, Inc. is a national leader in outpatient diagnostic imaging services, headquartered in Los Angeles, California. Founded in 1981, the company operates a network of 435 freestanding, fixed-site imaging centers across Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas, and Virginia, making it the largest provider of its kind in the United States. RadNet offers a comprehensive suite of imaging modalities including MRI, CT, PET, nuclear medicine, mammography, ultrasound, X-ray, and fluoroscopy. The company operates two core business segments: Imaging Centers and Digital Health. Its Digital Health division develops and deploys AI-powered clinical applications designed to enhance radiologist interpretation of breast, lung, prostate, and brain imaging. RadNet also provides integrated, cloud-based medical imaging workflow solutions through its IT division, eRAD, and pursues strategic growth through joint ventures with hospitals, health systems, and accountable care organizations.
Company Leadership

